
Neeraj Sharma
Examiner (ID: 5222, Phone: (571)270-5487 , Office: P/2659 )
| Most Active Art Unit | 2659 |
| Art Unit(s) | 2659, 2626 |
| Total Applications | 582 |
| Issued Applications | 475 |
| Pending Applications | 51 |
| Abandoned Applications | 71 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5760728
[patent_doc_number] => 20060211673
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-21
[patent_title] => 'Modulation of neurodegenerative diseases through the estrogen receptor'
[patent_app_type] => utility
[patent_app_number] => 11/365968
[patent_app_country] => US
[patent_app_date] => 2006-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9028
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0211/20060211673.pdf
[firstpage_image] =>[orig_patent_app_number] => 11365968
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/365968 | Modulation of neurodegenerative diseases through the estrogen receptor | Feb 28, 2006 | Abandoned |
Array
(
[id] => 5859771
[patent_doc_number] => 20060229247
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-12
[patent_title] => 'T. cruzi-derived neurotrophic agents and methods of use therefor'
[patent_app_type] => utility
[patent_app_number] => 11/365743
[patent_app_country] => US
[patent_app_date] => 2006-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 38
[patent_no_of_words] => 25850
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20060229247.pdf
[firstpage_image] =>[orig_patent_app_number] => 11365743
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/365743 | T. cruzi-derived neurotrophic agents and methods of use therefor | Feb 27, 2006 | Issued |
Array
(
[id] => 6492501
[patent_doc_number] => 20100093616
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-15
[patent_title] => 'Combination of EGF/GHRP-6 for Neurogeneration of Central Nervous System Following Autoimmune Damage'
[patent_app_type] => utility
[patent_app_number] => 11/885330
[patent_app_country] => US
[patent_app_date] => 2006-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5317
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20100093616.pdf
[firstpage_image] =>[orig_patent_app_number] => 11885330
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/885330 | Combination of EGF/GHRP-6 for Neurogeneration of Central Nervous System Following Autoimmune Damage | Feb 23, 2006 | Abandoned |
Array
(
[id] => 5514246
[patent_doc_number] => 20090214552
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-27
[patent_title] => 'Novel Egg Receptors for Sperm Proteins'
[patent_app_type] => utility
[patent_app_number] => 11/915225
[patent_app_country] => US
[patent_app_date] => 2006-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 39
[patent_no_of_words] => 24962
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20090214552.pdf
[firstpage_image] =>[orig_patent_app_number] => 11915225
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/915225 | Novel Egg Receptors for Sperm Proteins | Feb 20, 2006 | Abandoned |
Array
(
[id] => 5625867
[patent_doc_number] => 20060264372
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-23
[patent_title] => 'Process for the synchronization of ovulation for timed breeding without heat detection'
[patent_app_type] => utility
[patent_app_number] => 11/357347
[patent_app_country] => US
[patent_app_date] => 2006-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4236
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 23
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0264/20060264372.pdf
[firstpage_image] =>[orig_patent_app_number] => 11357347
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/357347 | Process for the synchronization of ovulation for timed breeding without heat detection | Feb 16, 2006 | Abandoned |
Array
(
[id] => 5113519
[patent_doc_number] => 20070197435
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-23
[patent_title] => 'Process for the synchronization of ovulation for timed breeding without heat detection'
[patent_app_type] => utility
[patent_app_number] => 11/356884
[patent_app_country] => US
[patent_app_date] => 2006-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4248
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20070197435.pdf
[firstpage_image] =>[orig_patent_app_number] => 11356884
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/356884 | Process for the synchronization of ovulation for timed breeding without heat detection | Feb 16, 2006 | Abandoned |
Array
(
[id] => 5480089
[patent_doc_number] => 20090203046
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-13
[patent_title] => 'METHODS FOR IDENTIFYING PURKINJE CELLS USING THE CORL2 GENE AS A TARGET'
[patent_app_type] => utility
[patent_app_number] => 11/813743
[patent_app_country] => US
[patent_app_date] => 2006-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10200
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20090203046.pdf
[firstpage_image] =>[orig_patent_app_number] => 11813743
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/813743 | METHODS FOR IDENTIFYING PURKINJE CELLS USING THE CORL2 GENE AS A TARGET | Jan 31, 2006 | Abandoned |
Array
(
[id] => 5875186
[patent_doc_number] => 20060166884
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-27
[patent_title] => 'Purified rhlGF-I/rhlGFBP-3 complexes and their method of manufacture'
[patent_app_type] => utility
[patent_app_number] => 11/311633
[patent_app_country] => US
[patent_app_date] => 2005-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 6051
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20060166884.pdf
[firstpage_image] =>[orig_patent_app_number] => 11311633
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/311633 | Purified rhIGF-I/rhIGFBP-3 complexes and their method of manufacture | Dec 19, 2005 | Issued |
Array
(
[id] => 5672951
[patent_doc_number] => 20060178306
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-10
[patent_title] => 'Modulation of the neuroendoctrine system as a therapy for motor neuron disease'
[patent_app_type] => utility
[patent_app_number] => 11/294161
[patent_app_country] => US
[patent_app_date] => 2005-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 12523
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0178/20060178306.pdf
[firstpage_image] =>[orig_patent_app_number] => 11294161
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/294161 | Modulation of the neuroendoctrine system as a therapy for motor neuron disease | Dec 1, 2005 | Issued |
Array
(
[id] => 5367139
[patent_doc_number] => 20090304698
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-10
[patent_title] => 'MODULATION OF OVULATION'
[patent_app_type] => utility
[patent_app_number] => 11/720827
[patent_app_country] => US
[patent_app_date] => 2005-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 8255
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0304/20090304698.pdf
[firstpage_image] =>[orig_patent_app_number] => 11720827
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/720827 | MODULATION OF OVULATION | Dec 1, 2005 | Abandoned |
Array
(
[id] => 4704514
[patent_doc_number] => 20080064038
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-13
[patent_title] => 'Autism Genes and Regulated Secretion'
[patent_app_type] => utility
[patent_app_number] => 11/720056
[patent_app_country] => US
[patent_app_date] => 2005-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 18889
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 22
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0064/20080064038.pdf
[firstpage_image] =>[orig_patent_app_number] => 11720056
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/720056 | Autism Genes and Regulated Secretion | Nov 22, 2005 | Abandoned |
Array
(
[id] => 84085
[patent_doc_number] => 07741455
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-06-22
[patent_title] => 'Method for purifying FSH'
[patent_app_type] => utility
[patent_app_number] => 11/575833
[patent_app_country] => US
[patent_app_date] => 2005-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7112
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/741/07741455.pdf
[firstpage_image] =>[orig_patent_app_number] => 11575833
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/575833 | Method for purifying FSH | Nov 7, 2005 | Issued |
Array
(
[id] => 5801264
[patent_doc_number] => 20060035818
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-16
[patent_title] => 'Use of corticotroph-derived glycoprotein hormone to induce lipolysis'
[patent_app_type] => utility
[patent_app_number] => 11/253881
[patent_app_country] => US
[patent_app_date] => 2005-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5806
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20060035818.pdf
[firstpage_image] =>[orig_patent_app_number] => 11253881
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/253881 | Use of corticotroph-derived glycoprotein hormone to induce lipolysis | Oct 18, 2005 | Abandoned |
Array
(
[id] => 5743159
[patent_doc_number] => 20060088884
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-27
[patent_title] => 'Method of utilizing neurotrophins to manipulate reproductive capacity'
[patent_app_type] => utility
[patent_app_number] => 11/243619
[patent_app_country] => US
[patent_app_date] => 2005-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10474
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0088/20060088884.pdf
[firstpage_image] =>[orig_patent_app_number] => 11243619
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/243619 | Method of utilizing neurotrophins to manipulate reproductive capacity | Oct 4, 2005 | Issued |
Array
(
[id] => 4921496
[patent_doc_number] => 20080069811
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-20
[patent_title] => 'Fsh and Fsh Receptor Modulator Compositions and Methods for Inhibiting Osteclastic Bone Resorption and Bone Loss in Osteoporosis'
[patent_app_type] => utility
[patent_app_number] => 11/664030
[patent_app_country] => US
[patent_app_date] => 2005-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 16778
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20080069811.pdf
[firstpage_image] =>[orig_patent_app_number] => 11664030
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/664030 | Methods for inhibiting osteoclastic bone resorption and bone loss comprising administration of an anti-FSH or anti-FSHR antibody | Sep 26, 2005 | Issued |
Array
(
[id] => 270376
[patent_doc_number] => 07563612
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-07-21
[patent_title] => 'Recombinant bifunctional protein of human lutropin receptor and human chorionic gonadotropin B-subunit and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/235621
[patent_app_country] => US
[patent_app_date] => 2005-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 26986
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/563/07563612.pdf
[firstpage_image] =>[orig_patent_app_number] => 11235621
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/235621 | Recombinant bifunctional protein of human lutropin receptor and human chorionic gonadotropin B-subunit and uses thereof | Sep 25, 2005 | Issued |
Array
(
[id] => 270376
[patent_doc_number] => 07563612
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-07-21
[patent_title] => 'Recombinant bifunctional protein of human lutropin receptor and human chorionic gonadotropin B-subunit and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/235621
[patent_app_country] => US
[patent_app_date] => 2005-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 26986
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/563/07563612.pdf
[firstpage_image] =>[orig_patent_app_number] => 11235621
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/235621 | Recombinant bifunctional protein of human lutropin receptor and human chorionic gonadotropin B-subunit and uses thereof | Sep 25, 2005 | Issued |
Array
(
[id] => 270376
[patent_doc_number] => 07563612
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-07-21
[patent_title] => 'Recombinant bifunctional protein of human lutropin receptor and human chorionic gonadotropin B-subunit and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/235621
[patent_app_country] => US
[patent_app_date] => 2005-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 26986
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/563/07563612.pdf
[firstpage_image] =>[orig_patent_app_number] => 11235621
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/235621 | Recombinant bifunctional protein of human lutropin receptor and human chorionic gonadotropin B-subunit and uses thereof | Sep 25, 2005 | Issued |
Array
(
[id] => 270376
[patent_doc_number] => 07563612
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-07-21
[patent_title] => 'Recombinant bifunctional protein of human lutropin receptor and human chorionic gonadotropin B-subunit and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/235621
[patent_app_country] => US
[patent_app_date] => 2005-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 26986
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/563/07563612.pdf
[firstpage_image] =>[orig_patent_app_number] => 11235621
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/235621 | Recombinant bifunctional protein of human lutropin receptor and human chorionic gonadotropin B-subunit and uses thereof | Sep 25, 2005 | Issued |
Array
(
[id] => 5404479
[patent_doc_number] => 20090239793
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-24
[patent_title] => 'Polynucleotides and polypeptides associated with trophoblast cell death, differentiation, invasion, and/or cell fusion and turnover'
[patent_app_type] => utility
[patent_app_number] => 11/663678
[patent_app_country] => US
[patent_app_date] => 2005-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 41825
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 22
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0239/20090239793.pdf
[firstpage_image] =>[orig_patent_app_number] => 11663678
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/663678 | Polynucleotides and polypeptides associated with trophoblast cell death, differentiation, invasion, and/or cell fusion and turnover | Sep 22, 2005 | Abandoned |